BMT Q4 Outlook Report

Read also

• Biomedtracker: see the drug development process through anal...

  Q2 2022 Outlook Report

  23 May 2022

  In this report, we cover catalysts from 31 drugs, devices, diagnostics, and deals expected to occur in the second quarter of 2022.

  Topics $name

  View Infographic

• Biomedtracker: see the drug development process through anal...

  Don’t miss your free extract of Early 2022 Outlook Report

  In pharma’s fast paced and continually evolving world, accurately anticipating the impact of events on the horizon is critical to your success.

  Topics Business Strategies

  Single Report

• Biomedtracker: see the drug development process through anal...

  Key Potential Drug Launches in 2022

  Released July 22, 2021. Contains information like likelihood of approval (LOA) ratings and upcoming catalysts that are current as of April 2021.

  Single Report

• Biomedtracker: see the drug development process through anal...

  Q3 2021 Outlook Report

  What major drug catalysts and events can you expect to see in the months ahead? Download your free extract from the Q3 2021 Outlook Report and infographic to find out. Shape your strategy with your inside look at what’s to come.

  Topics Drug Review

  Single Report

• Datamonitor Healthcare: data analysis and insight, Biomedtra...

  2021 Post-ASCO Insights and Analysis

  The American Society of Clinical Oncology (ASCO) hosted its annual meeting from June 4-8 2021 and our team has the exclusive insights and analysis you can access today.

  Topics Cancer

  Single Report

• Biomedtracker: see the drug development process through anal...

  Plan for 2021 ASCO with Pharma Intelligence

  The Pharma Intelligence analyst team will be covering the 2021 ASCO virtual meeting from June 4-8, 2021.

  Single Report